Skip to main content
Journal cover image

A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.

Publication ,  Journal Article
Quinten, C; Martinelli, F; Coens, C; Sprangers, MAG; Ringash, J; Gotay, C; Bjordal, K; Greimel, E; Reeve, BB; Maringwa, J; Ediebah, DE ...
Published in: Cancer
January 15, 2014

BACKGROUND: The objective of this study was to examine the prognostic value of baseline health-related quality of life (HRQOL) for survival with regard to different cancer sites using 1 standardized and validated patient self-assessment tool. METHODS: In total, 11 different cancer sites pooled from 30 European Organization for Research and Treatment of Cancer (EORTC) randomized controlled trials were selected for this study. For each cancer site, univariate and multivariate Cox proportional hazards modeling was used to assess the prognostic value (P< .05) of 15 HRQOL parameters using the EORTC Core Quality of Life Questionnaire (QLQ-C30). Models were adjusted for age, sex, and World Health Organization performance status and were stratified by distant metastasis. RESULTS: In total, 7417 patients completed the EORTC QLQ-C30 before randomization. In brain cancer, cognitive functioning was predictive for survival; in breast cancer, physical functioning, emotional functioning, global health status, and nausea and vomiting were predictive for survival; in colorectal cancer, physical functioning, nausea and vomiting, pain, and appetite loss were predictive for survival; in esophageal cancer, physical functioning and social functioning were predictive for survival; in head and neck cancer, emotional functioning, nausea and vomiting, and dyspnea were predictive for survival; in lung cancer, physical functioning and pain were predictive for survival; in melanoma, physical functioning was predictive for survival; in ovarian cancer, nausea and vomiting were predictive for survival; in pancreatic cancer, global health status was predictive for survival; in prostate cancer, role functioning and appetite loss were predictive for survival; and, in testis cancer, role functioning was predictive for survival. CONCLUSIONS: The current results demonstrated that, for each cancer site, at least 1 HRQOL domain provided prognostic information that was additive over and above clinical and sociodemographic variables.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer

DOI

EISSN

1097-0142

Publication Date

January 15, 2014

Volume

120

Issue

2

Start / End Page

302 / 311

Location

United States

Related Subject Headings

  • Self-Assessment
  • Randomized Controlled Trials as Topic
  • Quality of Life
  • Proportional Hazards Models
  • Prognosis
  • Oncology & Carcinogenesis
  • Neoplasms
  • Multivariate Analysis
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Quinten, C., Martinelli, F., Coens, C., Sprangers, M. A. G., Ringash, J., Gotay, C., … Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer (EORTC) Clinical Groups, . (2014). A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer, 120(2), 302–311. https://doi.org/10.1002/cncr.28382
Quinten, Chantal, Francesca Martinelli, Corneel Coens, Mirjam A. G. Sprangers, Jolie Ringash, Carolyn Gotay, Kristin Bjordal, et al. “A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.Cancer 120, no. 2 (January 15, 2014): 302–11. https://doi.org/10.1002/cncr.28382.
Quinten C, Martinelli F, Coens C, Sprangers MAG, Ringash J, Gotay C, et al. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer. 2014 Jan 15;120(2):302–11.
Quinten, Chantal, et al. “A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.Cancer, vol. 120, no. 2, Jan. 2014, pp. 302–11. Pubmed, doi:10.1002/cncr.28382.
Quinten C, Martinelli F, Coens C, Sprangers MAG, Ringash J, Gotay C, Bjordal K, Greimel E, Reeve BB, Maringwa J, Ediebah DE, Zikos E, King MT, Osoba D, Taphoorn MJ, Flechtner H, Schmucker-Von Koch J, Weis J, Bottomley A, Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer (EORTC) Clinical Groups. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer. 2014 Jan 15;120(2):302–311.
Journal cover image

Published In

Cancer

DOI

EISSN

1097-0142

Publication Date

January 15, 2014

Volume

120

Issue

2

Start / End Page

302 / 311

Location

United States

Related Subject Headings

  • Self-Assessment
  • Randomized Controlled Trials as Topic
  • Quality of Life
  • Proportional Hazards Models
  • Prognosis
  • Oncology & Carcinogenesis
  • Neoplasms
  • Multivariate Analysis
  • Middle Aged
  • Male